However, our data suggest that following GSH depletion, NRF2 is stabilized, and this stabilization is associated with decreased expression of lipogenic enzymes and lower serum triglyceride levels
Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery
If you experience sharp pain, numbness, or prolonged swelling, contact your PlexusDx clinical team for guidance
Dosage and administration: Administered subcutaneously once weekly at any time of day, with or without meals
Stelara (ustekinumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $10.36 billion Why it sold so well: J&Js immunology blockbuster Stelara generated approximately $10.36 billion in global sales in 2024, a 4.6% decline from the previous year